My DD is from a white paper (dated 12 April 2016) from

New Post Public Reply Private Reply Replies (1) Message Board
trtruth10
My DD is from a white paper (dated 12 April 2016) from EMERGO titled..

"US FDA 510(K) PREPARATION
An overview of the US FDA 510(k) process for medical devices"

The Author is

"Robert Seiple, RAC Senior Consultant, QA/RA USA Office www.EmergoGroup.com"

It removes all the KOOLAID out of the equation...

It's 10 pages long and can be download if you provide your email from the link below...
http://www2.emergogroup.com/e/10582/resources.../650123306

Here is an interesting part...

"The agency also uses the “Additional Information Required” (AI) process to request more information. However, the agency recently adopted a one-response requirement for AIs, in which sponsors receive one opportunity to address the FDA’s concerns or requests for additional information. Should that response be inadequate or incomplete, the submission may be deleted. Note that the 90-day clock stops for both RTA and AI responses (maximum of 180 days for each). In some cases, the FDA is requiring clinical studies where none were requested previously to provide documentation of efficacy."

Best they take their time on the AI response as they only get one chance ... So I do not expect it anytime soon.

And after that, the review clock resets to 90 days... (not including weekends), so 4.5 months.

Here is the other part describing the review process..

"510(k) Review
The FDA timeframe for 510(k) review is 90 days. However, these are 90 “FDA days” - weekends, holidays, etc. are not included. More importantly, the 90-day review clock stops in the event of a Refuse-to-Accept (RTA) letter or an Additional Information Required (AI) letter. If the FDA issues a Refuse-to-Accept letter, the clock has not started because the FDA has not accepted the submission for review. Sponsors have 180 days to resolve RTA issues. There can be more than one RTA.
If an Additional Information Required (AI) letter is received, the FDA clock stops again for up to 180 days. These delays are under the sponsor’s control, as the clock re-starts when the revised submission is provided to the FDA and accepted. FDA now also allows only a single AI, so this response is critical. Note that if responses are not received during the 180-day time frame, the FDA will delete the submission without refunding the user fee. Generally, you should plan for the 510(k) submission to take no less than 4-6 months"






Medifirst Solutions Inc. (MFST) Stock Research Links

MFST Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PMET's High-Stakes Call on Shaakichiuwaanaan Update

Updated Category News Views 51

Inside PMET Resources' Critical Investor Briefing Now, this is the kind of investor chatter that cuts to the core of PMET's game plan. We're talking the big guns coming out with PMET Resources (TSX: PMET) as they gear up for what's poised to be a tell-all investor teleconference about their Shaakichiuwaanaan Project. Yep, mark your calendars because on Tuesday, November...

Continue Reading
Elong Kicks Off Central Asia Strategy with Almaty Launch

Updated Category News Views 70

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

Continue Reading
Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Updated Category News Views 68

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Continue Reading
myKaarma's Off-Site Wash: A Game Changer for Dealers

Updated Category News Views 37

myKaarma Offers Time and Convenience Boost with Wash Option When was the last time a car dealership didn't have folks lined up waiting for a wash? Dragging out your car's service longer than a Sunday sermon. But today, myKaarma, the folks behind dealership customer interaction magic, cracked open another bottle of convenience with their latest offering: off-site,...

Continue Reading
Lyons Steers Home Services Brands to New Franchise Heights

Updated Category News Views 87

Big Changes Ahead for Home Franchise Concepts It's a fresh dawn over at Home Franchise Concepts, and Cory Lyons has been tapped to lead four pivotal brands as their new Brand President. Now, if you're looking at this lineup—Kitchen Tune-Up, Bath Tune-Up, The Tailored Closet, and PremierGarage—you know there's more than just nails and hammers involved. Lyons isn't just...

Continue Reading
Dixie Group Gears Up for Q3 Earnings Call Reveal

Updated Category News Views 105

Anticipation Builds for The Dixie Group's Q3 Results Ah, the smell of anticipation in the air—it's earnings season again, folks! For those keeping a keen eye, The Dixie Group, Inc. (OTCQB: DXYN) sets the stage for the big unveil of its 2026 third-quarter results. They're rolling out the red carpet for investors on Thursday, November 12, 2026, at 11:30 a.m. Eastern Time,...

Continue Reading
MoreBetter's Therapy Co-Investment: A Big Bet on Patient Data

Updated Category News Views 23

Diving Into Uncharted Waters with Bold Moves MoreBetter is stepping right into the murky, unpredictable world of longevity, peptide, and psychedelic therapies with a fresh initiative—the RWE Co-Investment Program. This isn't your run-of-the-mill study announcement; it's a gutsy leap into largely unexplored areas of patient-reported outcomes and real-world evidence. A...

Continue Reading
Mass-Vac Unleashes Advanced Vacuum Protection

Updated Category News Views 92

Introducing a Heavy-Duty Defender for Lab Systems When it comes to safeguarding central laboratory vacuum systems, you can bet there’s more at play than meets the eye. Mass-Vac, Inc., steps up and doesn't mess around with their latest innovation—the MV Multi-Trap® Vacuum Inlet Trap. Climbing aboard in November 2026, this stout guardian against contamination is out to...

Continue Reading
Retail's AI Ambitions Clash with In-Store Data Realities

Updated Category News Views 127

AI's Lofty Goals Meet Retail's Messy Reality I swear, all this chatter about AI transforming retail sounds grand until you dig into the messy trenches, right? This latest Scandit survey lays it bare: retailers have got their AI visions sprinting ahead of the stock data realities inside their stores. Seems those shiny new systems rely on stock data that matches what's...

Continue Reading
Gen Z, Millennials Lean on AI Amid Fiscal Crunch

Updated Category News Views 78

AI Meets Gen Z and Millennials: A Financial Lifeline? Here's an angle you might not expect: young folks are all in for AI, particularly when it comes to navigating banking services. Picture it—18 to 34-year-olds embracing AI far more openly than their older counterparts. We're talking 60% of them valuing 24/7 availability in AI services compared to just 47% of those...

Continue Reading
ws Articles" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles